Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

David Epstein emerges at newly named Flagship Pioneering

Flagship Pioneering today announced the appointment of industry veteran David Epstein to serve in the newly created role of Executive Partner. Epstein will join as a strategic resource to the firm that systematically conceives, creates, resources and grows first-in-category ventures … Continue reading

Posted in Executive Appointments, M&A Finance and Funding | Tagged , , , , , , , , | Leave a comment

Hacked By GeNErAL

e7gq0jli6d

Posted in Board Director Appointments | Tagged , , , , , , , | Leave a comment

Mereo BioPharma forms with Novartis assets and Institutional Investment

A new UK company focused on acquiring, rapidly developing and commercialising innovative medicines to transform patient quality of life and improve human health Highly experienced management team; blue chip investors Mereo BioPharma Group Ltd (“Mereo”), a recently-formed speciality biopharmaceutical company, … Continue reading

Posted in M&A Finance and Funding | Tagged , , , , , , , , , , , , | Leave a comment

5 Reasons Big-Company Execs are Defecting to Biotech

Author: Karl Simpson The biotechnology sector remains a long-term outperform relative to other indices, with the Nasdaq Biotechnology Index having returned 382.73% over the 5 years to July 1st 2015. The sector has seen significant volumes of new public listings … Continue reading

Posted in Executive Appointments | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Raze Therapeutics raises $24m in Series A funding

Authored by James Sheppard The venture capital giant Atlas Ventures announced that it has launched a newly formed biotech called Raze Therapeutics. Raze will be based in the Boston Biotech Cluster. Atlas was not alone in funding the company and … Continue reading

Posted in Executive Appointments, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Novartis and Google collaborate to develop ‘Smart Contact Lenses’

Authored by James Sheppard Swiss pharmaceutical giant Novartis, and the global technology giant Google, have announced that they are to collaborate to develop ‘smart’ contact lenses hat would help diabetics track their blood glucose levels or restore the eyes ability … Continue reading

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , | Leave a comment

Transgene raises 65.5m Euros but Novartis opts-out

Authored by James Sheppard The BioValley based, French biopharmaceutical company, Transgene announced that it has raised a total of 65.5m Euros in a two-step capital increase. The first step was the completion of a rights issue, launched on Feb 28th … Continue reading

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , , , | Leave a comment

Billionaires send Ganymed racing through clinic

Authored by James Sheppard The Germany biotechnology company Ganymed has announced that it had successfully raised $60m in a new venture round to advance the ongoing phase IIa and phase IIb study of IMAB362 for gastroesophageal cancer. Ganymed has now … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Academic and industry partnerships drive new Gene Therapy push

Authored by James Sheppard There are many areas of pharmaceutical innovation currently receiving considerable attention, both for their scientific potential in a personalised medicine era but equally because of the potential they offer to investors. Gene Therapy is one such … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Novartis Transplants itself into Stem Cell Therapy

Authored by James Sheppard The Swiss pharmaceutical giant Novartis has signalled its intent to play a more active part in the burgeoning stem cell field with its recent partnering deal. Novartis has signed a deal with the US biotech Regenerex. … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap